Mohamed Rafi Mohamed Ismail is a Senior Pharmacovigilance Associate at ICON plc, where they have been working since 2022. They possess broad industry experience in pharmacovigilance, focusing on the collection and review of clinical trial and post-marketing safety data. Previously, Mohamed gained valuable experience as a Drug Safety Associate at PRA Health Sciences from 2019 to 2022. With a strong foundation in regulatory compliance and quality processes, they have demonstrated expertise in managing safety reports and ensuring adherence to guidelines set by regulatory authorities.
Location
Mannheim, Germany
This person is not in any offices